On this episode of Stock Movers:
- European pharmaceutical stocks may be active after the US government said Tuesday that it negotiated a 71% discount of the list price of Novo Nordisk's drugs Ozempic and Wegovy for patients in Medicare. 
- Pernod Ricard is dipping after JPMorgan is taking a generally cautious stance on European consumer staples heading into 2026, with higher unemployment and low consumer confidence expected to see delivery again weighted to second half of the year, driven by fiscal packages and easier comparatives. 
- Next is one of the companies on the frontline in today's UK budget as companies watch for a possible patchwork of levies.

On this episode of Stock Movers: - European pharmaceutical stocks may be active after the US government said Tuesday that it negotiated a 71% discount of the list price of Novo Nordisk's drugs Ozempic and Wegovy for patients in Medicare.&nbsp; - Pernod Ricard is dipping after JPMorgan is taking a generally cautious stance on European consumer staples heading into 2026, with higher unemployment and low consumer confidence expected to see delivery again weighted to second half of the year, driven by fiscal packages and easier comparatives. - Next is one of the companies on the frontline in today's UK budget as companies watch for a possible patchwork of levies.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. Subscribe for analysis on the companies making news on Wall Street.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

Novo Nordisk's Discount, Pernod Ricard Dips, Next Jitters

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/75c4ae79-5756-4dfc-b559-b3a10096e33b/transcript

Advertisement